Novartis Investigative Site

Sumida-ku, Tokyo 130-8575

0 studies enrolling now · 2 studies all time

What they study most

Retinopathy of Prematurity, Retinopathy of Prematurity (ROP)

Studies at this site

• Rainbow Extension Study — Completed
• RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity — Completed